Saturday, July 11, 2026

Drug profile · INN

bromfenac

bromfenac (YELLOX) is a cyclooxygenase inhibitor.

EMA: approved NMPA: clinical trials Sensory organs (S01) S01BC11
Patents linked 1
Pipeline programs 2
News articles 0
Drug details — bromfenac
Class
Sensory organs (S01)
Route
Patents
1
Programs
2
Data quality
0.83

Quick answer

bromfenac (YELLOX) is a cyclooxygenase inhibitor.

Key facts

INN bromfenac
Brand YELLOX
Mechanism Cyclooxygenase inhibitor
Therapeutic class Sensory organs (S01)
ATC code S01BC11

Mechanism of action

Cyclooxygenase inhibitor

Approval history

Authority Status Date
EMA approved
NMPA clinical trials

Pipeline programs

  1. 0.1% bromfenac Approved · Zhongshan Ophthalmic Center · Pterygium
  2. 0.1% bromfenac ophthalmic solution Unknown · Chinese Academy of · Cataract

Related & competitor drugs

  1. aflibercept Sensory organs (S01)
  2. atropine sulfate Sensory organs (S01)
  3. bimatoprost Sensory organs (S01)
  4. atropine Sensory organs (S01)
  5. brinzolamide Sensory organs (S01)
  6. latanoprost Sensory organs (S01)

Related patents

  1. CA 2852995

    COMPOSITION OPHTALMIQUE QUI CONTIENT DU BROMFENAC PRESENTANT UNE BIODISPONIBILITE ACCRUE

    Expires Wed Apr 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is bromfenac?

bromfenac (YELLOX) is a cyclooxygenase inhibitor.

What is the brand name for bromfenac?

YELLOX is a marketed brand name for bromfenac. Check FDA Drugs@FDA for the current US label holder and prescribing information.